Table 2.

Any grade treatment-related AEs reported in at least 10% of patients

Adverse event<800 mg n = 9 n (%)800 mg n = 24 n (%)Total n = 33 n (%)
Decreased white cell count8 (89)21 (88)29 (88)
Lymphopenia9 (100)20 (83)29 (88)
Neutropenia5 (56)19 (79)24 (73)
Nausea6 (67)16 (67)22 (67)
Anemia5 (56)8 (33)13 (39)
Thrombocytopenia4 (44)7 (29)11 (33)
Vomiting3 (33)8 (33)11 (33)
Diarrhea2 (22)7 (29)9 (27)
Infection (any)0 (0)9 (38)9 (27)
Fatigue1 (33)5 (21)6 (18)
Lethargy0 (0)4 (17)4 (12)
Pruritis0 (0)4 (17)4 (12)
Rash1 (33)3 (13)4 (12)